Product Program year 2021 Source: CMS Open Payments

Clinical Trial Product

Device Pain Management

Open in the dashboard

General payments

$634,797

625 payments

Research payments

$0

0 payments

Through program year 2021, $634,797 in general payments and $0 in research payments were reported against Clinical Trial Product (Pain Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $634,797 625

Breakdown

Who paid General payments · program year 2021
  1. Boston Scientific Corporation $634,797 625 payments
Top recipients General payments · program year 2021
  1. Saint Lukes Hospital Of Kansas City Teaching hospital · MO $71,383 11% · 4 payments
  2. Ravi Ramana Interventional Cardiology · Palos Park, IL $59,700 9% · 9 payments
  3. Kenneth Rosenfield Cardiovascular Disease · Boston, MA $46,625 7% · 1 payment
  4. Yale Wang Interventional Cardiology · Minneapolis, MN $42,250 7% · 27 payments
  5. Jonathan Kleefield Neuroradiology · Boston, MA $40,675 6% · 37 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Cardiology Internal Medicine $182,927 35% · 15 practitioners
  2. Cardiovascular Disease Internal Medicine $127,121 24% · 22 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $43,338 8% · 28 practitioners
  4. Neuroradiology Radiology $40,675 8% · 1 practitioner
  5. Neurology Psychiatry & Neurology $27,180 5% · 3 practitioners

The top 5 of 38 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Massachusetts $196,328 31% · 17 recipients
  2. Minnesota $141,661 22% · 12 recipients
  3. Missouri $71,936 11% · 4 recipients
  4. Illinois $68,294 11% · 5 recipients
  5. New York $54,370 9% · 7 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

625 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record